Aldemar Degroot

1.6k total citations
21 papers, 1.0k citations indexed

About

Aldemar Degroot is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, Aldemar Degroot has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 14 papers in Cognitive Neuroscience and 8 papers in Pharmacology. Recurrent topics in Aldemar Degroot's work include Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Memory and Neural Mechanisms (10 papers). Aldemar Degroot is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Memory and Neural Mechanisms (10 papers). Aldemar Degroot collaborates with scholars based in United States, Canada and Netherlands. Aldemar Degroot's co-authors include Dallas Treit, George G. Nomikos, Ingrid K. Christoffels, Johannes Kroll, Marise B. Parent, Mark Wade, Shauna Kashluba, Richard J. Davis, Craig R. Salhoff and Eleni T. Tzavara and has published in prestigious journals such as Brain Research, Neuroscience and Neuropsychopharmacology.

In The Last Decade

Aldemar Degroot

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aldemar Degroot United States 17 538 453 253 197 188 21 1.0k
Harvey J. Altman United States 21 791 1.5× 566 1.2× 215 0.8× 186 0.9× 322 1.7× 39 1.3k
Gilberto N. O. Brito Brazil 18 428 0.8× 664 1.5× 82 0.3× 178 0.9× 132 0.7× 36 1.0k
D.N. Stephens United Kingdom 16 507 0.9× 482 1.1× 57 0.2× 54 0.3× 212 1.1× 34 1.0k
Sarah F. B. McTavish United Kingdom 17 538 1.0× 398 0.9× 145 0.6× 90 0.5× 211 1.1× 31 1.2k
Carmen Garcı́a-Lecumberri Spain 19 776 1.4× 199 0.4× 423 1.7× 83 0.4× 215 1.1× 30 1.0k
Munir Gunes Kutlu United States 20 627 1.2× 455 1.0× 86 0.3× 152 0.8× 612 3.3× 47 1.2k
Santiago Monleón Spain 17 339 0.6× 220 0.5× 108 0.4× 281 1.4× 116 0.6× 40 894
Nancy J. Leith United States 16 569 1.1× 201 0.4× 76 0.3× 106 0.5× 204 1.1× 20 771
Benjamin Kelmendi United States 16 334 0.6× 214 0.5× 272 1.1× 143 0.7× 138 0.7× 37 1.1k
Sheila E. Specio United States 12 794 1.5× 577 1.3× 68 0.3× 160 0.8× 384 2.0× 13 1.3k

Countries citing papers authored by Aldemar Degroot

Since Specialization
Citations

This map shows the geographic impact of Aldemar Degroot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldemar Degroot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldemar Degroot more than expected).

Fields of papers citing papers by Aldemar Degroot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldemar Degroot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldemar Degroot. The network helps show where Aldemar Degroot may publish in the future.

Co-authorship network of co-authors of Aldemar Degroot

This figure shows the co-authorship network connecting the top 25 collaborators of Aldemar Degroot. A scholar is included among the top collaborators of Aldemar Degroot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldemar Degroot. Aldemar Degroot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seager, Matthew A., Scott D. Gleason, Xia Li, et al.. (2018). Evaluation of 5-HT7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice. Behavioural Brain Research. 360. 270–278. 23 indexed citations
2.
Tzavara, Eleni T., Aldemar Degroot, Mark Wade, Richard J. Davis, & George G. Nomikos. (2008). CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: Role of mGlu5 receptors. European Neuropsychopharmacology. 19(3). 196–204. 20 indexed citations
3.
Degroot, Aldemar & George G. Nomikos. (2006). In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission. Current Opinion in Pharmacology. 7(1). 62–68. 23 indexed citations
4.
Degroot, Aldemar, Attila Köfalvi, Mark Wade, et al.. (2006). CB1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action. Molecular Pharmacology. 70(4). 1236–1245. 60 indexed citations
5.
Wade, Mark, Aldemar Degroot, & George G. Nomikos. (2006). Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents. European Journal of Pharmacology. 551(1-3). 162–167. 52 indexed citations
6.
Degroot, Aldemar & George G. Nomikos. (2006). Genetic deletion of muscarinic M4 receptors is anxiolytic in the shock-probe burying model. European Journal of Pharmacology. 531(1-3). 183–186. 13 indexed citations
7.
Degroot, Aldemar, Craig R. Salhoff, Richard J. Davis, & George G. Nomikos. (2005). Genetic deletion of CB1 receptors improves non-associative learning. Behavioural Brain Research. 162(1). 161–164. 16 indexed citations
8.
Degroot, Aldemar & George G. Nomikos. (2004). Fluoxetine Disrupts the Integration of Anxiety and Aversive Memories. Neuropsychopharmacology. 30(2). 391–400. 20 indexed citations
9.
Degroot, Aldemar & George G. Nomikos. (2004). Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock‐probe burying test. European Journal of Neuroscience. 20(4). 1059–1064. 45 indexed citations
10.
Degroot, Aldemar, Mary C. Wolff, & George G. Nomikos. (2004). Acute exposure to a novel object during consolidation enhances cognition. Neuroreport. 16(1). 63–67. 24 indexed citations
11.
Degroot, Aldemar & Dallas Treit. (2004). Anxiety is functionally segregated within the septo-hippocampal system. Brain Research. 1001(1-2). 60–71. 126 indexed citations
12.
13.
Degroot, Aldemar, Mark Wade, Craig R. Salhoff, et al.. (2004). Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide. European Journal of Pharmacology. 493(1-3). 103–109. 36 indexed citations
14.
Degroot, Aldemar, Tom J. Kornecook, Rémi Quirion, Suzanne DeBow, & Marise B. Parent. (2003). Glucose increases hippocampal extracellular acetylcholine levels upon activation of septal GABA receptors. Brain Research. 979(1-2). 71–77. 19 indexed citations
15.
Degroot, Aldemar & Dallas Treit. (2003). Septal gabaergic and hippocampal cholinergic systems interact in the modulation of anxiety. Neuroscience. 117(2). 493–501. 47 indexed citations
16.
Degroot, Aldemar & Dallas Treit. (2002). Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Research. 949(1-2). 60–70. 102 indexed citations
17.
Degroot, Aldemar, Shauna Kashluba, & Dallas Treit. (2001). Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Pharmacology Biochemistry and Behavior. 69(3-4). 391–399. 93 indexed citations
18.
Treit, Dallas, Aldemar Degroot, Shauna Kashluba, & Gerd D. Bartoszyk. (2001). Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test. European Journal of Pharmacology. 414(2-3). 245–248. 15 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harvey J. Altman Breakdown of academic impact, for papers by Gilberto N. O. Brito Breakdown of academic impact, for papers by D.N. Stephens Breakdown of academic impact, for papers by Sarah F. B. McTavish Breakdown of academic impact, for papers by Carmen Garcı́a-Lecumberri Breakdown of academic impact, for papers by Munir Gunes Kutlu Breakdown of academic impact, for papers by Santiago Monleón Breakdown of academic impact, for papers by Nancy J. Leith Breakdown of academic impact, for papers by Benjamin Kelmendi Breakdown of academic impact, for papers by Sheila E. Specio
Rankless by CCL
2026